Annual CFO:
-$142.77M+$117.60M(+45.17%)Summary
- As of today, CRSP annual cash from operations is -$142.77 million, with the most recent change of +$117.60 million (+45.17%) on December 31, 2024.
- During the last 3 years, CRSP annual cash from operations has fallen by -$681.75 million (-126.49%).
- CRSP annual cash from operations is now -126.49% below its all-time high of $538.97 million, reached on December 31, 2021.
Performance
CRSP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$113.88M-$59.93M(-111.10%)Summary
- As of today, CRSP quarterly cash from operations is -$113.88 million, with the most recent change of -$59.93 million (-111.10%) on June 30, 2025.
- Over the past year, CRSP quarterly cash from operations has dropped by -$18.30 million (-19.14%).
- CRSP quarterly cash from operations is now -114.11% below its all-time high of $807.00 million, reached on June 30, 2021.
Performance
CRSP Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$324.77M-$18.30M(-5.97%)Summary
- As of today, CRSP TTM cash from operations is -$324.77 million, with the most recent change of -$18.30 million (-5.97%) on June 30, 2025.
- Over the past year, CRSP TTM cash from operations has dropped by -$203.01 million (-166.73%).
- CRSP TTM cash from operations is now -159.11% below its all-time high of $549.43 million, reached on June 30, 2021.
Performance
CRSP TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CRSP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +45.2% | -19.1% | -166.7% |
| 3Y3 Years | -126.5% | +19.8% | +26.9% |
| 5Y5 Years | -351.9% | -288.9% | -111.2% |
CRSP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -126.5% | +71.2% | -203.8% | +14.5% | -166.7% | +34.5% |
| 5Y | 5-Year | -126.5% | +71.2% | -114.1% | +19.8% | -159.1% | +34.5% |
| All-Time | All-Time | -126.5% | +71.2% | -114.1% | +19.8% | -159.1% | +34.5% |
CRSP Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$113.88M(-111.1%) | -$324.77M(-6.0%) |
| Mar 2025 | - | -$53.95M(-7.8%) | -$306.47M(-114.7%) |
| Dec 2024 | -$142.77M(+45.2%) | -$50.03M(+53.2%) | -$142.77M(+24.4%) |
| Sep 2024 | - | -$106.91M(-11.9%) | -$188.82M(-55.1%) |
| Jun 2024 | - | -$95.58M(-187.1%) | -$121.76M(+23.6%) |
| Mar 2024 | - | $109.75M(+214.2%) | -$159.42M(+38.8%) |
| Dec 2023 | -$260.38M(+47.5%) | -$96.07M(-141.1%) | -$260.38M(+6.2%) |
| Sep 2023 | - | -$39.86M(+70.1%) | -$277.63M(+19.1%) |
| Jun 2023 | - | -$133.25M(-1614.3%) | -$342.99M(+2.5%) |
| Mar 2023 | - | $8.80M(+107.8%) | -$351.70M(+29.1%) |
| Dec 2022 | -$495.74M(-192.0%) | -$113.33M(-7.7%) | -$495.74M(-5.8%) |
| Sep 2022 | - | -$105.22M(+25.9%) | -$468.45M(-5.4%) |
| Jun 2022 | - | -$141.96M(-5.0%) | -$444.56M(-188.1%) |
| Mar 2022 | - | -$135.24M(-57.2%) | $504.40M(-6.4%) |
| Dec 2021 | $538.97M(+326.1%) | -$86.04M(-5.8%) | $538.97M(-0.9%) |
| Sep 2021 | - | -$81.33M(-110.1%) | $543.80M(-1.0%) |
| Jun 2021 | - | $807.00M(+901.7%) | $549.43M(+291.5%) |
| Mar 2021 | - | -$100.66M(-24.0%) | -$286.85M(-20.3%) |
| Dec 2020 | -$238.37M | -$81.21M(-7.3%) | -$238.37M(-55.0%) |
| Sep 2020 | - | -$75.70M(-158.5%) | -$153.78M(-377.9%) |
| Jun 2020 | - | -$29.28M(+43.9%) | $55.34M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$52.17M(-1645.5%) | $48.24M(-14.9%) |
| Dec 2019 | $56.68M(+158.9%) | $3.38M(-97.5%) | $56.68M(+127.4%) |
| Sep 2019 | - | $133.42M(+466.7%) | $24.93M(+119.4%) |
| Jun 2019 | - | -$36.38M(+16.8%) | -$128.46M(-9.5%) |
| Mar 2019 | - | -$43.74M(-54.2%) | -$117.29M(-21.9%) |
| Dec 2018 | -$96.24M(-37.3%) | -$28.37M(-42.1%) | -$96.24M(-16.4%) |
| Sep 2018 | - | -$19.96M(+20.8%) | -$82.71M(-5.2%) |
| Jun 2018 | - | -$25.21M(-11.1%) | -$78.61M(-13.3%) |
| Mar 2018 | - | -$22.69M(-52.9%) | -$69.37M(+1.0%) |
| Dec 2017 | -$70.09M(-32.6%) | -$14.84M(+6.5%) | -$70.09M(+9.1%) |
| Sep 2017 | - | -$15.87M(+0.7%) | -$77.12M(-8.5%) |
| Jun 2017 | - | -$15.97M(+31.8%) | -$71.08M(-3.4%) |
| Mar 2017 | - | -$23.41M(-7.1%) | -$68.71M(-24.2%) |
| Dec 2016 | -$52.86M(-188.9%) | -$21.87M(-122.6%) | -$55.31M(-65.4%) |
| Sep 2016 | - | -$9.82M(+27.8%) | -$33.44M(-41.6%) |
| Jun 2016 | - | -$13.60M(-35.8%) | -$23.62M(-86.1%) |
| Mar 2016 | - | -$10.01M(-273.7%) | -$12.69M(-197.8%) |
| Dec 2015 | $59.43M(+1339.9%) | - | - |
| Jun 2015 | - | -$2.68M(-69.3%) | -$4.26M(-169.3%) |
| Mar 2015 | - | -$1.58M | -$1.58M |
| Dec 2014 | -$4.79M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual cash from operations?
- What is the all-time high annual cash from operations for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual cash from operations year-on-year change?
- What is CRISPR Therapeutics AG quarterly cash from operations?
- What is the all-time high quarterly cash from operations for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly cash from operations year-on-year change?
- What is CRISPR Therapeutics AG TTM cash from operations?
- What is the all-time high TTM cash from operations for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM cash from operations year-on-year change?
What is CRISPR Therapeutics AG annual cash from operations?
The current annual cash from operations of CRSP is -$142.77M
What is the all-time high annual cash from operations for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual cash from operations is $538.97M
What is CRISPR Therapeutics AG annual cash from operations year-on-year change?
Over the past year, CRSP annual cash from operations has changed by +$117.60M (+45.17%)
What is CRISPR Therapeutics AG quarterly cash from operations?
The current quarterly cash from operations of CRSP is -$113.88M
What is the all-time high quarterly cash from operations for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly cash from operations is $807.00M
What is CRISPR Therapeutics AG quarterly cash from operations year-on-year change?
Over the past year, CRSP quarterly cash from operations has changed by -$18.30M (-19.14%)
What is CRISPR Therapeutics AG TTM cash from operations?
The current TTM cash from operations of CRSP is -$324.77M
What is the all-time high TTM cash from operations for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM cash from operations is $549.43M
What is CRISPR Therapeutics AG TTM cash from operations year-on-year change?
Over the past year, CRSP TTM cash from operations has changed by -$203.01M (-166.73%)